Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

The influence of cyclosporine a and rapamycin on the b cell subpopulations in vitro

P Wierzbicki, M Jastrzębska, D Kłosowska, A Korecka, G Korczak-Kowalska, A Górski

Ann Transplant 2009; 14(1): 69-69 :: ID: 880452

Abstract

Background: Data on the influence of immunosuppressive drugs on the generation and functions of the B cell subpopulations including B-1a, B1b, and conventional B2 are limited. B1 cells are important cell population producing natural antibodies and involved in antibacterial humoral responses. Among them B1a subset expresses the pan-T cell surface glycoprotein CD5. This molecule is known to modulate lymphocyte activation and differentiation processes. Compared to B2 cells, B1a are long-lived, non-circulating, with reduced BCR affinity.
Material/Methods: The aim of this study was to compare the effects of two
commonly used immunosuppressive drugs, i.e. cyclosporine A (a calcineurine inhibitor) and rapamycin (a cell division inhibitor), on the induction of the B cell subpopulations. Mononuclear cells were obtained from the whole peripheral blood of healthy blood donors. PBMCs were cultured for five days in the presence or absence of either drug. Then the percentages of CD19, CD11b, and CD5 positive cells on PWM-activated and non-activated cells were determined using appropriate monoclonal antibodies. Flow cytometry was performed with a FACSCalibur (BD Biosciences) and data were analyzed using Cell Quest software.
Results: Although both investigated drugs decreased the percentages of B-1a and B1b cells, the difference was statistically significant only in the B-1a subpopulation. On the other hand, neither drug affected the percentage of B2 cells.
Conclusions: The present study is preliminary and we intend to pursue this
line of research by evaluating the influence of immunosuppressive drugs on the functions of the major B cell subpopulations, especially their capability to produce antibodies.

Keywords: Immunosuppression

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358